Phase II Trial of Paclitaxel–Topotecan–Etoposide Followed by Consolidation Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: CALGB 30002 Antonius A. Miller, MD, Xiaofei F. Wang, PhD, Jeffrey A. Bogart, MD, Lydia D. Hodgson, MS, Caio M. S. Rocha Lima, MD, James E. Radford, MD, Everett E. Vokes, MD, Mark R. Green, MD Journal of Thoracic Oncology Volume 2, Issue 7, Pages 645-651 (July 2007) DOI: 10.1097/JTO.0b013e318074bbf5 Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 Study schema. ANC, absolute neutrophil count; AUC, area under the concentration curve. Journal of Thoracic Oncology 2007 2, 645-651DOI: (10.1097/JTO.0b013e318074bbf5) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 Failure-free survival. Journal of Thoracic Oncology 2007 2, 645-651DOI: (10.1097/JTO.0b013e318074bbf5) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 3 Overall survival. Journal of Thoracic Oncology 2007 2, 645-651DOI: (10.1097/JTO.0b013e318074bbf5) Copyright © 2007 International Association for the Study of Lung Cancer Terms and Conditions